These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 16886975

  • 21. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
    Coupez R, Straetemans R, Sehgal G, Stockis A, Lu ZS.
    J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of levetiracetam after oral and intravenous administration of a single dose to clinically normal cats.
    Carnes MB, Axlund TW, Boothe DM.
    Am J Vet Res; 2011 Sep; 72(9):1247-52. PubMed ID: 21879984
    [Abstract] [Full Text] [Related]

  • 23. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
    Algorta J, Pena MA, Alvarez A, Maraschiello C, Maruhn D, Windisch M, Mucke HA.
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
    [Abstract] [Full Text] [Related]

  • 24. Levetiracetam in social phobia: a placebo controlled pilot study.
    Zhang W, Connor KM, Davidson JR.
    J Psychopharmacol; 2005 Sep; 19(5):551-3. PubMed ID: 16166192
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM, van Vliet A, Abou Farha K, Cherrington JM, Campbell DA, Li X, Hanway D, Li J, Guler HP.
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [Abstract] [Full Text] [Related]

  • 26. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ, Arif H, Buchsbaum R, Weintraub D, Lee J, Chang JT, Resor SR, Bazil CW.
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [Abstract] [Full Text] [Related]

  • 27. A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog beta-methyl-6-chloromelatonin.
    Mulchahey JJ, Goldwater DR, Zemlan FP.
    Life Sci; 2004 Aug 27; 75(15):1843-56. PubMed ID: 15302228
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
    Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, Coupez R, Stockis A, Lu ZS.
    Epilepsia; 2007 Jun 27; 48(6):1117-22. PubMed ID: 17442002
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul 27; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 30. Tolerability and efficacy of oral loading of levetiracetam.
    Koubeissi MZ, Amina S, Pita I, Bergey GK, Werz MA.
    Neurology; 2008 May 27; 70(22 Pt 2):2166-70. PubMed ID: 18505995
    [Abstract] [Full Text] [Related]

  • 31. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
    Sardina M, Love R, Mizrahi J, Monzani V, Bianchini C.
    J Cardiovasc Pharmacol; 1995 May 27; 26 Suppl 4():S72-9. PubMed ID: 8839230
    [Abstract] [Full Text] [Related]

  • 32. Safety of rapid intravenous loading of valproate.
    Limdi NA, Knowlton RK, Cofield SS, Ver Hoef LW, Paige AL, Dutta S, Faught E.
    Epilepsia; 2007 Mar 27; 48(3):478-83. PubMed ID: 17319914
    [Abstract] [Full Text] [Related]

  • 33. Levetiracetam: safety and efficacy in neonatal seizures.
    Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J.
    Eur J Paediatr Neurol; 2011 Jan 27; 15(1):1-7. PubMed ID: 21094062
    [Abstract] [Full Text] [Related]

  • 34. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J, N01103 Levetiracetam Study Group.
    Epilepsia; 2009 Nov 27; 50(11):2377-89. PubMed ID: 19702752
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
    Christopher R, Covington P, Davenport M, Fleck P, Mekki QA, Wann ER, Karim A.
    Clin Ther; 2008 Mar 27; 30(3):513-27. PubMed ID: 18405789
    [Abstract] [Full Text] [Related]

  • 36. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S, Jullien V, Rey E, Dulac O, Chiron C, Pons G.
    Epilepsia; 2009 May 27; 50(5):1150-7. PubMed ID: 19175400
    [Abstract] [Full Text] [Related]

  • 37. Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjects.
    Mant T, Jurcevic S, Szakacs C, Adams L, Boland J, Hewitt LA.
    Clin Ther; 2008 Jan 27; 30(1):131-42. PubMed ID: 18343249
    [Abstract] [Full Text] [Related]

  • 38. Intravenous levetiracetam in clinical practice--Results from an independent registry.
    Lang N, Esser W, Evers S, Kellinghaus C, Nguento A, Schlegel U, Gaida B, Gburek-Augustat J, Altenmüller DM, Burghaus L, Hoffmann F, Fiedler B, Bast T, Rehfeld T, Happe S, Seitz RJ, Boor R, Stephani U.
    Seizure; 2015 Jul 27; 29():109-13. PubMed ID: 26076852
    [Abstract] [Full Text] [Related]

  • 39. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT, Hastriter EV, Cardenas JF, Khoury EM, Chapman KE.
    J Child Neurol; 2010 May 27; 25(5):551-5. PubMed ID: 20413804
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R, Sukbuntherng J, Luo W, Chen D, Vu A, Tovera J, Cundy KC.
    Clin Ther; 2009 Aug 27; 31(8):1776-86. PubMed ID: 19808136
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.